| scholarly article | Q13442814 |
| P50 | author | Richard W Steketee | Q72209511 |
| Bernard L Nahlen | Q89290178 | ||
| Venkatachalam Udhayakumar | Q60032286 | ||
| P2093 | author name string | Zhiyong Zhou | |
| Ya Ping Shi | |||
| Lisa B Mirel | |||
| Juliana A Otieno | |||
| John G Ayisi | |||
| Anna M van Eijk | |||
| Phillip Cullison Bonner | |||
| P2860 | cites work | Effect of antibodies to recombinant and synthetic peptides on P. falciparum sporozoites in vitro | Q68857855 |
| Transplacental transfer of rodent microfilariae induces antigen-specific tolerance in rats | Q70435074 | ||
| Characterisation and sequence of a protective rhoptry antigen from Plasmodium falciparum | Q27973809 | ||
| Identification of an erythrocyte binding peptide from the erythrocyte binding antigen, EBA-175, which blocks parasite multiplication and induces peptide-blocking antibodies | Q33761565 | ||
| Congenital exposure to Plasmodium falciparum antigens: prevalence and antigenic specificity of in utero-produced antimalarial immunoglobulin M antibodies | Q34714308 | ||
| Mechanisms by which maternal antibodies influence infant vaccine responses: review of hypotheses and definition of main determinants | Q35172908 | ||
| Risk factors for HIV infection among asymptomatic pregnant women attending an antenatal clinic in western Kenya. | Q38885317 | ||
| Short report: entomologic inoculation rates and Plasmodium falciparum malaria prevalence in Africa. | Q38900161 | ||
| Maternal placental infection with Plasmodium falciparum and malaria morbidity during the first 2 years of life | Q39164333 | ||
| Protective immunization with invariant peptides of the Plasmodium falciparum antigen MSA2. | Q39433305 | ||
| Epidemiology, malaria and pregnancy | Q40186527 | ||
| Cellular mechanisms of immunologic tolerance | Q40204557 | ||
| A longitudinal investigation of IgG and IgM antibody responses to the merozoite surface protein-1 19-kiloDalton domain of Plasmodium falciparum in pregnant women and infants: associations with febrile illness, parasitemia, and anemia. | Q40640896 | ||
| Receptor and ligand domains for invasion of erythrocytes by Plasmodium falciparum. | Q41460430 | ||
| Sialic acid-dependent binding of baculovirus-expressed recombinant antigens from Plasmodium falciparum EBA-175 to Glycophorin A. | Q43545546 | ||
| Prenatal immune priming in malaria: antigen-specific blastogenesis of cord blood lymphocytes from neonates born in a setting of holoendemic malaria. | Q44484949 | ||
| Maternal filarial infection as risk factor for infection in children | Q45229624 | ||
| Adherence of Plasmodium falciparum to chondroitin sulfate A in the human placenta | Q45249046 | ||
| Long-term effect of prenatal exposure to maternal microfilaraemia on immune responsiveness to filarial parasite antigens | Q46434056 | ||
| Analysis of repeated hemoglobin measures in full-term, normal birth weight Kenyan children between birth and four years of age. III. The Asemobo Bay Cohort Project | Q47246954 | ||
| Plasmodium falciparum infection of the placenta affects newborn immune responses | Q47675155 | ||
| Inhibition of 19-kDa C-terminal region of merozoite surface protein-1-specific antibody responses in neonatal pups by maternally derived 19-kDa C-terminal region of merozoite surface protein-1-specific antibodies but not whole parasite-specific anti | Q47725661 | ||
| Inflammatory reactions in placental blood of Plasmodium falciparum-infected women and high concentrations of soluble E-selectin and a circulating P. falciparum protein in the cord sera | Q47831862 | ||
| Neonatal exposure to immunogenic peptides. Differential susceptibility to tolerance induction of helper T cells and B cells reactive to malarial circumsporozoite peptide epitopes. | Q47887773 | ||
| Longitudinal study of natural immune responses to the Plasmodium falciparum apical membrane antigen (AMA-1) in a holoendemic region of malaria in western Kenya: Asembo Bay Cohort Project VIII. | Q47888403 | ||
| Acquired immune responses to Plasmodium falciparum merozoite surface protein-1 in the human fetus | Q47896543 | ||
| Plasmodium falciparum variant surface antigen expression varies between isolates causing severe and nonsevere malaria and is modified by acquired immunity | Q47901577 | ||
| Failure of malaria vaccination in mice born to immune mothers. II. Induction of specific suppressor cells by maternal IgG | Q47974725 | ||
| Protection against clinical malaria by heterologous immunoglobulin G antibodies against malaria-infected erythrocyte variant surface antigens requires interaction with asymptomatic infections | Q47997112 | ||
| P433 | issue | 3 | |
| P921 | main subject | Kenya | Q114 |
| malaria | Q12156 | ||
| Plasmodium falciparum | Q311383 | ||
| P304 | page(s) | 375-379 | |
| P577 | publication date | 2005-03-01 | |
| P1433 | published in | Clinical and Vaccine Immunology | Q5133811 |
| P1476 | title | Placental malaria diminishes development of antibody responses to Plasmodium falciparum epitopes in infants residing in an area of western Kenya where P. falciparum is endemic | |
| P478 | volume | 12 |
| Q37285306 | Acquisition of natural humoral immunity to P. falciparum in early life in Benin: impact of clinical, environmental and host factors |
| Q37332194 | Associations between maternal helminth and malaria infections in pregnancy and clinical malaria in the offspring: a birth cohort in entebbe, Uganda |
| Q33487651 | Can prenatal malaria exposure produce an immune tolerant phenotype? A prospective birth cohort study in Kenya |
| Q36717617 | Epidemiology and burden of malaria in pregnancy |
| Q90701475 | Impact of malaria in pregnancy on risk of malaria in young children: systematic review and meta-analyses |
| Q24814453 | Maternal malaria and gravidity interact to modify infant susceptibility to malaria |
| Q40410115 | Placental malaria increases malaria risk in the first 30 months of life |
| Q26315542 | Plasmodium malaria and antimalarial antibodies in the first year of life |
| Q35907438 | The risk of malaria in Ghanaian infants born to women managed in pregnancy with intermittent screening and treatment for malaria or intermittent preventive treatment with sulfadoxine/pyrimethamine |
Search more.